By Bryan Koenig ( January 13, 2016, 3:38 PM EST) -- Abbott Laboratories asked a Texas federal judge Tuesday to rethink her decision forcing the company to face a whistleblower's False Claims Act lawsuit alleging it marketed stents for off-label uses, arguing that it need only show its marketing was "objectively reasonable" to evade the claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.